There is controversy regarding the therapeutic role for cerclage in treating patients with painless dilatation and shortening of the cervix during the second trimester of pregnancy. Results of cerclage placement are acknowledged to be less successful when the cervix is markedly effaced or widely dilated and the membranes are visible or protruding. 1 Several authors have reported fetal survival rates ranging from 47% to 89% after therapeutic cerclage, albeit the data are from uncontrolled studies. 2 Higher salvage rates and lower complication rates were correlated with less advanced cervical changes. Antibiotics and indomethacin have also been used as adjuncts Obstetrical and Gynecological Society, Kamuela, Hawaii, November 14-19, 2000. Reprint requests: Miles J. Novy, MD, Oregon Regional Primate Research Center, 505 NW 185th Ave, Beaverton, OR 97006. Copyright © 2001 by Mosby, Inc. 0002-9378/2001.00 + 0 6/6/114854 doi: 10.1067/mob.2001.114854 Cervical cerclage in the second trimester of pregnancy: A historical cohort study Beaverton and Portland, Oregon OBJECTIVE: The purpose of this study was to compare second-trimester transvaginal cervical cerclage with conservative management on duration of pregnancy and perinatal outcome in patients with early or advanced cervical changes. STUDY DESIGN: A historical cohort analysis was performed. Maternal and neonatal records between 1995 and 1999 were retrospectively reviewed for women presenting between 18 and 27 weeks of gestation with early cervical changes (length <3 cm, dilatation <2 cm, funneling of fetal membranes shown by transvaginal ultrasonography) (group 1, n = 31) and for women with advanced cervical effacement and dilatation (cervical dilatation ≥2 cm but ≤5 cm, fetal membranes visible) (group 2, n = 39). In each group, patients who underwent Shirodkar or McDonald cerclage were compared with patients treated conservatively with bed rest. Both groups also received multifactorial treatment with tocolytic agents, broad-spectrum antibiotics, and indomethacin. Outcome variables were analyzed for statistical significance by parametric and nonparametric methods. RESULTS: Regardless of treatment method, patients with early cervical changes (group 1) were given a diagnosis earlier and delivered later in pregnancy compared with their counterparts who had advanced cervical changes (group 2) (P < .05). In both patients who underwent cerclage and those treated conservatively, the mean birth weight among surviving infants was higher and the mean neonatal intensive care unit stay was shorter in group 1 than in group 2 (P < .02). However, duration of maternal hospital stay and neonatal survival rates were not different. In both groups 1 and 2, the interval from treatment to delivery, the mean gestational age at delivery, and mean birth weight were increased, whereas neonatal intensive care unit stay was decreased by cerclage treatment (P < .05). In group 1, a higher percentage of patients treated with cerclage received antibiotics and indomethacin than did control subjects (P < .01), whereas in group 2, the use of multifactorial treatment was not different (P = .5). The duration of maternal hospital stay and neonatal survival did not differ significantly among patients treated conservatively or with cerclage. CONCLUSIONS: Diagnosis of premature cervical changes by ultrasonography was correlated with treatment earlier in gestation and with a favorable impact on perinatal outcome in both patients treated with cerclage and those treated conservatively. Cervical cerclage was associated with an improved perinatal outcome (in comparison with conservative therapy) in women with early cervical changes detected by ultrasonography and in patients with advanced cervical dilatation and visible membranes. However, the apparent therapeutic effect of cerclage in patients with mild cervical incompetence may be due in part to an increased use of antibiotics and indomethacin in conjunction with cerclage. (Am J Obstet Gynecol 2001;184:1447-56.) 
There is controversy regarding the therapeutic role for cerclage in treating patients with painless dilatation and shortening of the cervix during the second trimester of pregnancy. Results of cerclage placement are acknowledged to be less successful when the cervix is markedly effaced or widely dilated and the membranes are visible or protruding. 1 Several authors have reported fetal survival rates ranging from 47% to 89% after therapeutic cerclage, albeit the data are from uncontrolled studies. 2 Higher salvage rates and lower complication rates were correlated with less advanced cervical changes. Antibiotics and indomethacin have also been used as adjuncts to cerclage as part of a multifactorial treatment plan. 3 According to Goodlin 4 expectant management of patients with bulging membranes between 23 and 27 weeks' gestation was inevitably associated with preterm delivery and a fetal survival rate of 20%. Similar pessimistic results were reported by Varma et al. 5 Despite these observations, many clinicians remain skeptical about cerclage and prefer a more conservative approach. Although there have been sporadic reports touting the benefit of bed rest and medical therapy, these observations are also uncontrolled. 6 In contrast, a recent prospective study (albeit nonrandomized) demonstrated that secondtrimester emergency cerclage resulted in a significantly higher mean infant birth weight compared with conservative management with bed rest. 7 The current practice of monitoring cervical length at midpregnancy by ultrasonography has identified a group of patients who manifest a shortened cervical canal, funneling of the fetal membranes, or mild cervical dilatation and who are at increased risk for preterm delivery. [8] [9] [10] The optimal management of early cervical changes in such patients remains to be determined and is the subject of considerable interest and current research. 11, 12 To address these therapeutic dilemmas, we have conducted a retrospective study (historical cohort analysis) that compares the effectiveness of cerclage with nonsurgical management of pregnancies complicated by early or advanced cervical changes during the second trimester.
Patients and methods
A computer-assisted review of maternal and neonatal records from January 1995 to July 1999 was conducted (according to procedures approved by the institutional review board) for patients who were given a diagnosis of early or advanced cervical changes between 18 and 27 weeks' gestation, by the obstetrics service at Oregon Health Sciences University Hospital in Portland, Oregon. This study includes the authors' patients from 3 affiliated perinatal practices.
Cervical changes were ascertained by sterile speculum examination and/or transvaginal ultrasonography in asymptomatic women during routine prenatal screening and in symptomatic women who presented with complaints such as low back pain, pelvic pressure, mild cramping, or mucus discharge. The procedure previously described by Iams et al 13 was used for measuring cervical length. In addition, the presence or absence of funneling was noted.
Selection criteria for inclusion in this series of patients were as follows. For group 1 (early cervical changes), inclusion criteria were (1) cervical length <3 cm, (2) marked cervical softening or effacement <60%, (3) funneling of the fetal membranes beyond the internal os but not visible at the external os, and (4) external os closed or dilated <2 cm. For group 2 (advanced cervical changes), inclusion criteria were (1) cervical effacement ≥60%, (2) cervical dilation ≥2 cm but not >5 cm, and (3) visible protrusion of intact fetal membranes beyond the internal cervical os or bulging at or beyond the external os. All patients demonstrated (1) a live intrauterine pregnancy of >18 weeks' and <27 weeks' gestation with no evidence of fetal anomalies, (2) absence of established labor, (3) favorable initial response to tocolysis, (4) absence of vaginal bleeding, and (5) absence of clinical evidence of chorioamnionitis. Women with a history of uterine anomaly, previous cervical cerclage, or a known medical cause for midtrimester abortion or preterm labor were excluded.
Patients treated with cerclage (n = 39) were compared with patients treated with bed rest (control subjects, n = 31). All of the patients were counseled about the possible outcomes of cerclage or conservative management with bed rest and adjunctive medical treatment consisting of tocolysis, broad-spectrum antibiotics, and indomethacin. Some women were treated conservatively with bed rest either because their physicians advised against surgical intervention or because they themselves refused surgery.
After the diagnosis of cervical effacement or dilatation was made, all women were admitted to the labor and delivery suite for observation and for continuous heart rate monitoring and uterine activity monitoring by external tocodynamometer. Patients were placed in a moderate Trendelenburg position, and if irregular uterine contractions were present, tocolysis was achieved by intravenous administration of magnesium sulfate or administration of terbutaline, 0.25 mg, given subcutaneously, according to standard procedures. The patient evaluation protocol included cervical and urine cultures for aerobic and facultative bacteria. Cultures for genital mycoplasma organisms and amniotic fluid cultures were infrequently performed. After 4 to 24 hours of observation, patients were admitted to the hospital for conservative management or were taken to the operating room after informed consent had been obtained.
Therapeutic cerclage procedures were performed, after general or conduction anesthesia had been induced, by a modified Shirodkar cerclage technique with the use of a 5-mm Mersilene tape (Ethicon RS-21 or D-8113; Ethicon Inc, Somerville, NJ), which has previously been described in detail. 3 Alternatively, and according to physician preference, a modified McDonald purse-string cerclage was performed with one or more large nonabsorbable monofilament sutures (eg, No. 1 Ethilon or Prolene; Ethicon Inc). Prophylactic intravenous broad-spectrum antibiotics (eg, cefoxitin, cefotetan, or Unasyn) were administered in the operating room, and treatment was continued for a minimum of 24 to 72 hours after operation. Patients received magnesium sulfate or β-mimetic agents as necessary for postoperative tocolysis.
Indomethacin (100-150 mg daily in divided doses) was offered for 2 to 5 days as part of a multifactorial treatment regimen. Ambulation was instituted gradually, and patients were discharged several days after operation.
Patients treated with bed rest without cerclage were also given similar multifactorial treatment during their hospitalization including tocolytic agents, broad-spectrum antibiotics, and indomethacin at the discretion of their physicians. Patients were not confined to the hospital for the duration of their pregnancies, but if feasible, they were discharged and bed rest was continued at home. After discharge, the condition and cervical status of patients in both groups were monitored at frequent intervals on an outpatient basis. Patients were routinely advised against having sexual intercourse. Women were readmitted to the hospital if preterm labor or rupture of membranes occurred. Glucocorticoids were administered to patients at risk for premature delivery between 27 and 33 weeks' gestation. Cervical sutures were removed at 36 to 37 weeks' gestation or whenever labor supervened. Cesarean delivery was performed for standard obstetric indications only.
Statistical analysis. Results were expressed as mean ± SEM. Data were analyzed with SAS statistical software (SAS Institute, Cary, NC). Continuous variables were analyzed by Kruskal-Wallis analysis of variance or the Student t test and dichotomous variables by χ 2 analysis. A P value of <.05 was considered significant.
Results
A historical cohort of 70 women, who met the inclusion criteria described previously, was identified during the study interval. The demographic characteristics of the study population are listed in Table I . There were no significant differences between the sample of patients treated with cerclage and the sample treated conservatively (or among the subgroups) with respect to age, gravidity, parity, previous preterm deliveries or abortions, race, or socioeconomic status as judged indirectly by health care provider status (eg, health maintenance organization, third-party insurance, or public assistance).
In group 1, 80% of the patients were found to have premature cervical changes (shortening, membrane funneling, and minimal dilatation) at routine sonographic screening, in contrast to group 2, in which the majority of patients were identified by means of clinical examination (cervix dilated and membranes visible or bulging in 83%); the cervical changes were ascertained by sonography in 32% of the women (P < .05).
Conservatively treated patients in group 1, compared with their counterparts in group 2, tended to be given a diagnosis 1.7 weeks earlier in gestation (P = .09), with less cervical dilatation, and delivered infants with higher birth weights, on average, 3.8 weeks later in pregnancy (P = .03). Although the fetal survival rate (73% vs 75%) did not differ, the neonatal intensive care unit (NICU) stay was shorter by 41 days in group 1 (P = .002). Similar significant trends were observed in patients treated with cerclage who had early cervical changes (group 1) in comparison with patients treated with cerclage who had advanced changes (group 2). The neonatal survival rate in group 1 patients treated with cerclage was 95% compared with 80% in group 2 (P = .07), and the NICU stay was significantly shorter by 24 days in group 1 (P = .02). The numerical data for these comparisons are provided in Table II .
The effects of the two different treatment regimens (ie, cervical cerclage vs conservative management) on duration of pregnancy, perinatal outcome, duration of maternal antepartum hospitalization, and NICU stay are compared in Tables III and IV for patients in group 1 and group 2, respectively. Cerclage therapy, compared with conservative management in both groups 1 and 2, was associated with a longer interval from diagnosis to delivery, a later gestational age at delivery, a higher infant birth weight, and shorter duration of neonatal intensive care (all statistically significant). There was no difference among groups in the length of maternal antepartum hospitalization. Although the fetal survival rate was slightly higher with cerclage compared with bed rest in group 2 (80% vs 75%), this difference was not statistically significant. In patients with early cervical changes (group 1), a higher fetal survival rate was associated with cerclage (95%) compared with conservative management (73%), and this difference approached statistical significance (P = .06). Table V provides additional data that relate to the frequency of Shirodkar versus McDonald cerclage use and the utilization rate of tocolytic, antibiotic, and antiinflammatory therapy in patients treated with cerclage and those treated with bed rest. In group 1, antibiotics and indomethacin were used more frequently in patients treated with cerclage than in those treated with bed rest (P < .09 and P < .005, respectively). In group 2, tocolytic agents, antibiotics, and indomethacin were used equally in patients treated with cerclage and those treated conservatively (P = .3 to .9). The prevalence of pregnancy complications, such as multiple gestation, premature rupture of membranes, chorioamnionitis, and cesarean delivery, in the two groups is given in Table VI . No significant differences in these outcomes were noted.
Comment
Most published articles on the efficacy of cervical cerclage are reports of case series. As such, they are open to various criticisms, notably that uncontrolled clinical observations will not support a consensus on the purported benefits from cerclage. Although there have been 2 casecontrol studies 14, 15 and 4 published prospective, randomized, controlled trials of cerclage [16] [17] [18] [19] in the older literature, the results of these studies have not been conclusive. In the largest trial sponsored by the Medical Research Council/Royal College of Obstetricians and Gynaecologists, the results suggest a beneficial effect of cerclage, with 13% in the cerclage group and 20% in the control group delivering before 33 weeks' gestation. 16 As discussed in detail elsewhere, 2, 20 careful scrutiny of each of the earlier randomized trials on cerclage indicates flaws in their study design and execution. From our perspective, the most serious flaws include confounding by combining elective with therapeutic cerclage procedures and a variable time of registration (in some cases, patients were admitted to the study from 10 to 28 weeks' gestation). In addition, the results were not always clearly separated according to the trimester in which the cerclage was applied or according to whether the intervention was based on preexisting factors or evolving cervical changes.
Given these circumstances, we were encouraged to perform a historical cohort analysis of maternal and neonatal records over a 4-year period that compares the effectiveness of "therapeutic" cerclage with the nonsurgical management of pregnancies complicated by evolving early or advanced cervical changes during the second trimester. Because previous studies 1, 2 had suggested that cerclage placement was less successful when the cervix was widely dilated, we segregated our data according to cervical status (ie, length, effacement, dilatation, and funneling or protrusion of membranes at the external os). We found that patients with evolving early cervical changes (group 1) were identified predominantly by screening ultrasonography at an average of 1.7 weeks earlier in the second trimester of pregnancy in comparison with patients who had more advanced cervical changes (group 2) who in turn tended to be symptomatic and were identified clinically. Patients in group 1, whether treated conserva- tively or with cerclage, delivered later in pregnancy (an average of 3.8 to 5.1 weeks, respectively), and their infants had mean birth weights approximately 750 g higher than those in group 2. Although the aggregate neonatal survival rates in group 1 (84%) and group 2 (77%) did not differ, infants of mothers with early cervical changes (compared with those with advanced changes) experienced significantly shorter stays in the NICU, regardless of the method of treatment (Table  II) . These results support previous observations that sonographic diagnosis of cervical incompetence allows earlier intervention, either medically or surgically, potentially prolonging gestation in patients at risk for delivering extremely premature infants. 21 Our data, which compare cerclage application with conservative management in patients with early cervical changes (Table III) , are consistent with the reports by Guzman et al 22 and preliminary results from the Cervical Incompetence Prevention Randomized Cerclage Trial. 10 They differ from the results of a nonrandomized prospective cohort study by Berghella et al 23 and the randomized trial reported recently by Rust et al. 12 Guzman et al 22 conducted a historical comparison of cervical cerclage versus bed rest after a diagnosis of cervical incompetence (progressive cervical shortening to < 2 cm) was made on the basis of sonographic findings in patients between 20 and 24 weeks' gestation. Adjuvant treatment with antibiotics or anti-inflammatory agents was not mentioned. Cerclage placement resulted in significant prolongation of pregnancy, with 79% of women delivering at or beyond 37 weeks in comparison with 35% of those treated with bed rest only (P = .04). 22 Berghella et al 23 monitored patients from 14 to 23 weeks' gestation by means of transvaginal ultrasonography, and McDonald cerclage was performed at the discretion of the physician and patient when cervical length was <25 mm or if funneling was >25%. The incidence of preterm delivery was not different (27% vs 23%, respectively; P = .7), and the days from diagnosis to delivery were similar (111 vs 96 days, respectively; P = .2). No mention was made of antibiotic or indomethacin use. Differences in outcomes between these two studies may be due to the shorter cervical length at which cerclage was performed by Guzman et al. 22 Rust et al 12 reported the results of a randomized prospective trial of cervical cerclage in a well-defined group of patients in the second trimester. The trial was limited to patients with dilatation of the internal os with membrane funneling and shortening of the endocervical canal diagnosed by means of sonography between 16 and 24 weeks' gestation. As such, it addresses the therapeutic dilemma in patients with early signs of functional cervical incompetence who are comparable with patients in group 1 of this study. A unique feature of the study by Rust et al 12 was the use of amniocentesis to rule out active infection and pretreatment with a broad-spectrum antibiotic and indomethacin for 48 hours in all patients before randomization. Because the outcome measures did not differ in the cerclage group and in those treated without cerclage (eg, mean gestation at delivery was 33.5 weeks and 34.7 weeks, respectively, P = .4), the authors concluded that McDonald cerclage treatment of early cervical incompetence in the second trimester of pregnancy does not improve perinatal outcome.
Although the Cervical Incompetence Prevention Randomized Cerclage Trial 10 trial was originally designed to compare prophylactic cerclage with expectant management, there was a secondary random assignment of 18 patients in whom short cervical length developed at a mean gestation of 19.1 weeks. Of these, 10 were allocated to undergo therapeutic cerclage. Both patients with and without cerclage received equal treatment with broadspectrum antibiotics and indomethacin for several days. Preterm delivery at <34 weeks' gestation was significantly less frequent in the therapeutic cerclage group (1/10 vs 5/8; P = .04). Despite the differences in study design and in treatment methods cited previously, a high rate of premature delivery has consistently been observed in patients with cervical shortening and funneling. This supports the hypothesis that sonographic diagnosis of membrane funneling beyond the internal os presages a more advanced form of functional cervical incompetence and represents a high-risk condition that is linked to preterm birth. 10, [23] [24] [25] The evidence from Iams et al 8, 13 that the risk of preterm birth increases as cervical length shortens suggests that "cervical incompetence" is not a categorical "all-or-none" phenomenon but a continuous variable (risk factor) for preterm birth.
The results of Guzman et al 22 suggest that even in the absence of treatment with antibiotics and anti-inflammatory agents, patients with marked cervical shortening may still derive a benefit from application of a cervical cerclage. The possible mechanism of this benefit could be the closure of the external os or the elongation of the endocervical canal, thereby fortifying maternal defenses against ascending infection (eg, lengthening the cervical mucus column, which has antimicrobial properties). 26 The results of the two randomized trials are at odds with one another. Rust et al 12 indicate that cerclage does not confer an added benefit to antibiotic and anti-inflammatory therapy in the majority of patients with mild functional cervical incompetence (length ≤2 cm with funneling). Nonetheless, such patients need careful and frequent monitoring until 28 to 30 weeks' gestation because the cervix may shorten and dilate further and because a few of the medically treated patients will require a rescue cerclage. On the other hand, the preliminary results from the Cervical Incompetence Prevention Randomized Cerclage Trial 10 strongly suggest that there is a synergistic effect of cerclage, antibiotics, and indomethacin in a multifactorial approach. 10 Given the inconsistencies among these studies, it is not possible, in our opinion, to conclude that cerclage has no benefit in managing early cervical changes.
It is of interest that our group 1 patients treated with cerclage achieved a slightly better perinatal outcome than did patients treated with cerclage in the study by Rust et al, 12 whereas our conservatively treated patients fared less well than their counterparts. We attribute this difference to the significantly lower utilization of indomethacin and antibiotics in our group 1 patients without cerclage in comparison with those in our cerclage group (Table V) or in comparison with all of the patients studied by Rust et al. 12 Thus although our data cannot be taken to prove that cerclage is beneficial for early cervical incompetence, they do support the use of antibiotics and anti-inflammatory agents in this clinical setting. Therefore we continue to advocate an aggressive multifactorial approach in managing functional cervical incompetence in the second trimester (combining tocolytic therapy, antibiotics, inhibition of prostaglandin synthesis, and a selective use of cervical cerclage). 3 The biologic basis for this approach is derived from mounting evidence that microbial factors play an important role in a large percentage of previously unexplained preterm births. 27 We know that cervical or vaginal microflora and the inflammatory reactions they elicit produce cytokines, prostaglandins, and matrix metalloproteinases, which initiate or promote cervical ripening. In our opinion, the relative importance of antibiotics and anti-inflammatory agents and the determination of specific criteria for the optimal use of cerclage in this setting will need to be established in future randomized studies.
Despite occasional reports of successful treatment of intrauterine infection with broad-spectrum antibiotics, the presence of microorganisms in the amniotic fluid signifies a poor prognosis. 28 There is ample evidence to show that application of an emergency cerclage before recognition of microbial invasion of the amniotic fluid results in a low fetal survival rate. 29 Although it is prudent to evaluate the microbial status of the amniotic cavity before placing a cerclage, this is seldom done in clinical practice in the absence of uterine contractions or in cases of mild cervical incompetence. In this regard, the study by Rust et al 12 is unique in that all patients had amniocentesis performed before randomization and treatment. However, their good success in both patients treated with bed rest and those treated with cerclage cannot be attributed to this precaution because no amniotic fluid cultures were positive in 60 patients. 12 The patient with advanced cervical effacement and dilatation of the cervix and with membranes at the level of the external os or protruding into the vagina presents a formidable therapeutic challenge. At 27 to 28 weeks' gestation and thereafter, such patients are usually treated expectantly with bed rest and tocolysis, and more recently, with antibiotic therapy. 27, 30 Although in most NICUs survival rates exceed 90% for infants with birth weights >1000 g, short-term morbidity and the expense of neonatal intensive care are high up to 33 weeks' gestation. The survival rate of infants weighing 500 to 999 g is only 60%, and of these survivors, one fourth are moderately to severely handicapped. 27 Therefore every reasonable effort should be made to prolong gestation safely for the previable or very low birth weight fetus.
The results of our retrospective study suggest that therapeutic cerclage before 27 weeks' gestation plays an important role in improving perinatal outcome (judged by later gestation at delivery, higher infant birth weights, and shorter duration of neonatal intensive care) in patients with advanced cervical changes (group 2, Table  IV) . Cervical cerclage was also associated with a trend toward higher neonatal survival rates. We used the Shirodkar method for cerclage more often than the McDonald procedure (Table V) . In our experience, the Shirodkar technique, as previously modified, 3 has the following ad-vantages for therapeutic, as well as emergency, cerclage: (1) placement closer to the uterine-isthmic junction, (2) stronger circumferential support by Mersilene tape, (3) less chance of suture erosion, and (4) protection of membranes from accidental puncture or abrasion because of paracervical rather than intracervical placement of the suture. Identification and removal of the anterior submucosal knot is facilitated by leaving a cut end of the Mersilene tape protruding through the vaginal incision.
When we analyze the results in group 2, we find that the utilization rate of antibiotics and indomethacin was similar in patients with and without cerclage (P = .5, P = .3; Table V ). In view of the substantial and significant improvement in perinatal outcome with cerclage in group 2, we conclude that cervical cerclage does provide a therapeutic benefit in treating the patient with advanced dilatation and visible membranes. Our results support and extend the observations of Olatunbosun et al 7 who conducted a nonrandomized prospective cohort study by recruiting patients with widely dilated cervices (cervical effacement >50% and dilatation ≥4 cm) between 20 and 27 weeks' gestation who elected either cerclage or conservative management with bed rest. Tocolytic agents, broadspectrum antibiotics, and indomethacin were administered in both groups. Although the perinatal mortality rate in the two groups was not significantly different, therapeutic cerclage resulted in a later mean gestation at delivery (33 weeks vs 28.8 weeks, P < .05), a significantly shorter duration of maternal antepartum hospitalization, and a higher mean infant birth weight compared with conservative bed rest treatment. The authors concluded that treatment with cervical cerclage was superior to bed rest in women with advanced cervical dilatation and absent labor in the late second trimester of pregnancy. Our results differ from theirs in that we did not find a longer maternal hospital stay in patients treated without cerclage. This was probably attributable to our physicians' tendency to encourage bed rest at home when deemed safe and because a larger percentage of our patients treated with bed rest than our patients treated with cerclage delivered before 28 weeks.
As we have emphasized, there is an important role for adjuvant medical therapy (tocolysis, antibiotics, and antiinflammatory agents) in the perioperative period and in the ongoing treatment of patients with cerclage. 3 Mounting evidence from clinical and animal studies provides a basis for a multifactorial approach to functional cervical incompetence. 27, 31 We have previously demonstrated that patients with wide cervical dilatation and prolapsed membranes have high circulating basal and post-cerclage prostaglandin metabolite levels. 32 A historical comparison from the literature indicates a higher success rate with cerclage when adjunctive antibiotics and antiinflammatory agents are used, 27 whereas retrospective control groups with widely dilated cervices and protruding membranes have low fetal survival rates and a poor chance of reaching term. 4, 5 Finally, indirect support for the use of antibiotics in the patient with functional cervical incompetence comes from multicenter studies and randomized trials, which indicate that antibiotic treatment of the patient with early preterm labor significantly prolongs pregnancy, reduces the risk of amnionitis, and improves perinatal outcome. 30 As we have previously stated, a successful cerclage procedure does not prevent the ripening process, but it does hold a distensible cervix closed while the adjunctive medical therapy is directed to remove the inciting stimuli and to restore homeostasis.
In summary, our results indicate that an aggressive multifactorial approach to advanced cervical dilatation and effacement before 27 weeks' gestation is associated with prolongation of pregnancy and improvements in perinatal outcome without an apparent increase in maternal complications such as amnionitis, premature rupture of membranes, extended antepartum hospitalization, or a high rate of cesarean delivery. Although the multifactorial approach is based on well-defined pathophysiologic mechanisms, the relative importance of each component (or the future addition of new agents such as cytokine inhibitors) will need continuing evaluation in randomized studies, especially in those patients with sonographic evidence of early cervical changes. There is also the opportunity to determine which surgical technique is most appropriate for transvaginal cerclage. Proponents of the Shirodkar approach claim that it is more effective than the McDonald technique, but no formal randomized comparison has yet been made.
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Editors' note:
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Discussion

DR T. MURPHY GOODWIN, Los Angeles, California.
With this report, Dr Novy continues to share with this society his long-standing interest in the problem of cervical incompetence.
This is a timely report. The increasing application of transvaginal ultrasonography of the cervix (TVS) has opened up the possibility of earlier and more accurate diagnosis of cervical changes, which previously were identified only late in the course. These advances in diagnosis, however, while shedding light on some of the fundamental controversies regarding the natural history of cervical incompetence, have raised new questions.
There is a consensus that women with a classic history of incompetence should undergo prophylactic cerclage. On the other hand, there has been controversy for years about the extent to which cervical weakness or insufficiency (something short of complete incompetence) contributes to problems other than classic second-trimester loss, such as early preterm birth. Before the advent of TVS, this question was addressed by a study in which all patients with a history of preterm birth were randomly assigned to cerclage versus conservative management. 1 The results of that study suggested that some premature births, albeit few, could be prevented by cerclage.
TVS holds out the hope of clarifying which patients with these histories suggestive of a cervical factor would benefit from intervention but brings its own new controversies:
1. Not every patient with a short cervix needs intervention to prevent preterm birth or loss. As Iams et al (see reference 13 of article) has clearly shown, the same length of cervix means something quite different in the woman with a history of term birth compared with one with history of preterm birth.
2. For patients who do require intervention, it is not known whether cerclage is better than bed rest. It is the goal of the current study to address this question.
In the study at hand, women between 18 and 27 weeks' gestation (some with risk factors, some without) were identified either by routine examination or in response to symptoms. Some intervention was believed to be needed. As in many communities, the management preferences (or biases) of the participating practitioners ac-counted for the distribution of the patients between conservative management and cerclage groups. Although there was some uniformity in practice in the community, there were significant differences in some areas of management such as the use of antibiotics and indomethacin and type of cerclage.
For the analysis of the data, the patients were divided into two groups based on cervical findings at initial presentation (group 1 with early cervical changes and group 2 with advanced cervical changes). The two groups did not differ significantly in baseline characteristics. As one would expect, patients in the group with early cervical changes were more often identified by means of TVS alone.
Although this study is not randomized and represents, basically, the combined experience of a group of practitioners, it does contribute to our understanding of the role of cerclage and bed rest in some patients with cervical changes. Within each group, cervical cerclage appeared to offer greater benefit than bed rest alone. Patients who were in the group with more advanced dilatation did not do as well as those in the other group, in aggregate, whether treated with bed rest or cerclage.
It is interesting to consider this report in the context of two randomized controlled trials in the American Journal of Obstetrics and Gynecology. Rust et al 2 found no benefit of cerclage compared with bed rest in 60 patients at moderate to low risk of preterm birth who were found to have cervical changes on transvaginal scan only. In direct contrast is a paper presented at the same meeting and published in the American Journal of Obstetrics and Gynecology by Althuisius et al 2 showing that among patients at high risk for early preterm birth, those who demonstrated shortening of the cervix in the late second trimester appeared to benefit more from cerclage than from bed rest. In both studies, the degree of cervical changes noted at enrollment was somewhat less than described by Dr Novy for his early cervical change group. Thus one of the main benefits of Dr Novy's study is in understanding the different treatment approaches for those patients with advanced cervical changes. These patients have not been subjected to randomized studies and are not likely to be. The type of information we have heard today with regard to this clinical problem, which every obstetrician will face, is what we have to guide us, imperfect as it is.
For patients with lesser degrees of cervical change, the answer will be found in the randomized controlled trials that are ongoing. As we have seen, there is still controversy. An indirect insight for design and interpretation of these studies is provided by Dr Novy's observations that the possible role of precocious cervical change in response to inflammation must be controlled for by uniform use of antibiotics and anti-inflammatory agents in these studies.
1. Can you clarify how patients were allotted to treatment with cerclage versus bed rest? Was this entirely due to individual physician and patient preferences or were there other systematic influences?
2. Given the importance of patient history in interpreting the findings of TVS, how many patients had what risk factors for preterm birth?
3. The longer gestation in the group with advanced cervical changes who received conservative treatment suggests a particular unwillingness to operate at these longer gestations. How many patients underwent cerclage after 24 weeks' gestation? DR RICHARD PAUL, Los Angeles, California. You have shown us pretty convincing data that transvaginal scanning has benefits. Could you tell us when you would recommend beginning that screening procedure and how often you would perform it in monitoring a patient who has a suggested history? DR LINDA ECKHERT, Seattle, Washington. Dr Novy, were you able to pre-screen the vaginal flora before placing the cerclage, and if so, what might be the impact of bacterial vaginosis on the outcome of your patients? DR KENNETH WELCH, Scottsdale, Arizona. Dr Novy, I wonder what role fetal fibronectin might play in evaluating who of the first group should undergo cerclage? DR MARK NICHOLS, Portland, Oregon. I am interested in the treatment regimen that you used with indomethacin. I know your group has, in the past, shown an increased level of prostaglandin metabolites after placement of cerclage, and so the question is, was the indomethacin used as a perioperative preventative treatment or was it ongoing? DR TAMEROU ASRAT, Long Beach, California. In your patients in group 1 in whom you placed a cerclage, what percentage of those patients had a cerclage because of the finding of funneling alone, without any decrease in the cervical length? I ask this because, as you know, it is controversial as to whether funneling means anything in the presence of a normal cervical length.
DR NOVY (Closing). Regarding the risk analysis, both groups of patients were comparable for demographic and historical risk factors, although there was insufficient information to accurately assess the prevalence of bacterial vaginosis. Despite the acknowledged importance of historical risk assessment for preterm birth prediction, it has limitations because nearly 50% of preterm births occur in low-risk patients 1 ; and in most studies, including ours, a substantial number of patients are primigravid. The advantage of transvaginal sonography as a screening device is that it measures the net effect of past and present risk factors on the cervix (eg, obstetrical history, in-fectious factors, host defense mechanisms, and the immune response). Incidentally, the vast majority of patients in group 1 had a combination of short cervical length and funneling.
Although there are inherent risks of selection bias in any cohort study, we sought to minimize them by insisting on strict patient inclusion and exclusion criteria. We were also fortunate that there were practitioners at the university and in the community who were skeptical about the benefits of cerclage so that we were able to record the results of conservative management. There was no real difference in gestation at diagnosis among patients treated conservatively or with cerclage. Among patients with advanced cervical changes, 73% had cerclage between 20 and 24 weeks' gestation; 5 patients received conservative treatment, and 4 patients had cerclage after 24 weeks' gestation but before 27 weeks' gestation. Indomethacin and antibiotics were used in the perioperative period.
In earlier work by Iams et al, 2 cervical ultrasonography was initiated at 24 weeks' gestation. More recent observations suggest that better predictive values can be achieved (especially for severe prematurity) when cervical scanning is begun at 18 to 22 weeks. Unfortunately, it is not possible to establish exact guidelines for the minimum frequency with which one should perform serial measurements of cervical length. Individualized patient management is appropriate based on risk factors and the extent of cervical change noted at the first visit. A mean decrease in cervical length of 0.5 to 0.8 cm per week between 21 and 24 weeks' gestation has been reported in patients at risk for preterm delivery. 3 It has also been demonstrated that functional cervical incompetence is a continuous process and that the relative risk for preterm delivery increases exponentially as the cervix shortens. 2 Thus it is possible that the different outcomes from controlled studies of cerclage may be explained in part by differences in the sonographic measurements of endocervical length and the extent of cervical funneling in the patients studied.
In conclusion, our philosophy is that a successful cerclage procedure does not reverse the ripening process once it is established but that it holds a distensible cervix closed while the adjunctive medical therapy is directed to remove the inflammatory stimuli.
